The Chocolate Touch Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 333 participants.

Also called NCT02924857

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 333 participants (enrolled count) (from the registry)
Sponsor
TriReme Medical, LLC (from the registry)
Registry
  • NCT NCT02924857
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Germany, New Zealand (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT02924857. Randomized; single masking; primary purpose treatment. Start 2017-07-26 (actual); primary completion 2025-06 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Chocolate Touch Study
Condition
Peripheral Artery Disease (PAD)
Condition
Ischemia
Intervention (Device)
Chocolate Touch
Intervention (Device)
Lutonix Drug Coated Balloon
Lead sponsor
TriReme Medical, LLC (class: industry)

Record details

Record id
cardio:ct-nct02924857
Content hash
c2613da58a60a46e625998f452f8cba39675408f05b136849c5524e832ba9416